AKT1 and colorectal carcinoma: Recently, we identified a new pathway by which TGFβ/PKA/PP2A signaling deactivates Akt phosphorylation leading to downregulation of IAPs, XIAP and survivin in colorectal cancer (CRC) cells[10,11].